Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody targets the p19 subunit of interleukin 23. Mirikizumab can be used for the research of ulcerative colitis.
Purity:
>98.0%
CAS Number:
[1884201-71-1]
Target:
IL Receptor/Related
* VAT and and shipping costs not included. Errors and price changes excepted